- Home
- CDNL vs MDXG Comparison
CDNL vs MDXG Comparison
Compare CDNL & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CDNL | MDXG |
|---|---|---|
| Founded | 2013 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 980.9M | 530.2M |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | CDNL | MDXG |
|---|---|---|
| Price | $52.07 | $3.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $38.00 | $9.00 |
| AVG Volume (30 Days) | 459.0K | ★ 1.5M |
| Earning Date | 05-12-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.29 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $418,630,000.00 |
| Revenue This Year | $50.30 | N/A |
| Revenue Next Year | $8.41 | $13.02 |
| P/E Ratio | $0.01 | ★ N/A |
| Revenue Growth | N/A | ★ 19.99 |
| 52 Week Low | $21.98 | $3.03 |
| 52 Week High | $63.18 | $7.99 |
Technical Indicators
Market Signals| Indicator | CDNL | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 51.89 | 51.81 |
| Support Level | $46.60 | $3.45 |
| Resistance Level | $54.55 | $3.80 |
| Average True Range (ATR) | 4.86 | 0.12 |
| MACD | -0.62 | 0.03 |
| Stochastic Oscillator | 32.09 | 65.71 |
Price Performance
Historical ComparisonAbout CDNL Cardinal Infrastructure Group Inc. Class A Common Stock
Cardinal Infrastructure Group Inc provides a comprehensive suite of infrastructure services to the residential, commercial, industrial, municipal, and state infrastructure markets. Its operations leverage a large highly skilled workforce and a fleet of specialized equipment to deliver wet utility installations (water, sewer, and stormwater systems), as well as grading, site clearing, erosion control, drilling and blasting, paving, and other related site services.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.